explore -WSS

explore

author：explore 2025-09-29 21:14:26 - browse：7423

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Why some people catch Covid but never get sick

WSS

iTeos Therapeutics debuts first data on TIGIT

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Medical experts are missing from AI regulatory conversations

What will save rural psychiatry services? Higher Medicaid payments

knowledge

explore

knowledge

Apple is now the first public company to be valued at $3 trillion

AI used to predict Covid

Medical records are filled with copy

Why the Crimean Bridge is key to Russia's war in Ukraine

At least 13 dead in Texas as scorching temps continue

Researchers separate signal from noise in heart wearable data

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

AI used to predict Covid

DIEP, the 'gold standard' of breast reconstruction, is under threat

Addiction doctors spar with methadone clinics over legislation

entertainment

David Sabatini, ex

Latest bird flu infection made farmworker sicker than earlier cases

Trump got a 'target letter.' What is one and what does it mean?

Antibiotic resistance nearly killed me, so I'm raising awareness of it

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

Lindsay Lohan welcomes 1st child with husband Bader Shammas

explore

focus

hotspot

hotspot